• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼索地平对离体工作兔心脏去内皮大冠状动脉的作用。

Effect of nisoldipine on de-endothelialized large coronary artery in isolated working rabbit hearts.

作者信息

Saeed M, Hartmann A, Bing R J

机构信息

Huntington Medical Research Institutes, Pasadena, Calif.

出版信息

Pharmacology. 1987;35(5):256-63. doi: 10.1159/000138318.

DOI:10.1159/000138318
PMID:3423101
Abstract

The effect of nisoldipine on coronary vascular resistances, cardiac performance and myocardial oxygen consumption was determined. Rabbit hearts were perfused with a perfluorochemical (FC-43) emulsion. Endothelium was removed from the obtuse marginal and the upper portion of the anterior descending coronary artery. Changes in the internal diameter of these arteries were visualized using injection of Patent Blue Dye (color arteriography). Mean internal diameter of coronary arteries and surface area/unit length were computer calculated. Nisoldipine reduced the constriction of coronary arteries and the decrease on coronary flow induced by histamine. Nisoldipine abolished or reduced the decrease in cardiac output, LVESP, dP/dt and myocardial oxygen consumption. The results demonstrate that in the supported rabbit heart preparation, nisoldipine is an effective dilator of large subepicardial coronary arteries, deprived of endothelial lining, and counteracts constriction of coronary resistance vessels. As a consequence nisoldipine improves performance of the ischemic myocardium.

摘要

研究了尼索地平对冠状动脉阻力、心脏功能和心肌耗氧量的影响。用全氟化合物(FC - 43)乳剂灌注兔心脏。去除钝缘支和冠状动脉前降支上段的内皮。通过注射专利蓝染料(彩色动脉造影)观察这些动脉内径的变化。计算机计算冠状动脉的平均内径和单位长度表面积。尼索地平可减轻组胺诱导的冠状动脉收缩和冠状动脉血流减少。尼索地平消除或减轻了心输出量、左心室收缩末期压、dp/dt和心肌耗氧量的降低。结果表明,在支持的兔心脏制备中,尼索地平是大的心外膜下冠状动脉(无内皮)的有效扩张剂,并可对抗冠状动脉阻力血管的收缩。因此,尼索地平可改善缺血心肌的功能。

相似文献

1
Effect of nisoldipine on de-endothelialized large coronary artery in isolated working rabbit hearts.尼索地平对离体工作兔心脏去内皮大冠状动脉的作用。
Pharmacology. 1987;35(5):256-63. doi: 10.1159/000138318.
2
Nisoldipine as a vasodilator in endothelium-deprived large coronary arteries of isolated working rabbit hearts.尼索地平在离体工作兔心去内皮大冠状动脉中作为血管扩张剂的作用。
Eur Heart J. 1989 Nov;10 Suppl F:159-63. doi: 10.1093/eurheartj/10.suppl_f.159.
3
Effect of nisoldipine on large coronary arteries in situ: inhibition of vasoconstriction induced by vasopressin.尼索地平对在位大冠状动脉的作用:抑制血管加压素诱导的血管收缩。
Pharmacology. 1988;37(2):85-93. doi: 10.1159/000138451.
4
Effect of nisoldipine on coronary resistance, contractility and oxygen consumption of the isolated blood-perfused canine left ventricle.尼索地平对离体血液灌注犬左心室冠脉阻力、收缩性及耗氧量的影响。
J Pharmacol Exp Ther. 1988 Mar;244(3):1000-4.
5
Effect of 8-bromo-cyclic guanosine monophosphate (cGMP) on coronary artery constriction in isolated rabbit hearts.8-溴环磷酸鸟苷(cGMP)对离体兔心冠状动脉收缩的影响。
J Am Coll Cardiol. 1986 Aug;8(2):342-8. doi: 10.1016/s0735-1097(86)80049-3.
6
Acute coronary hemodynamic effects of equihypotensive doses of nisoldipine and diltiazem.尼索地平与地尔硫䓬等效降压剂量对急性冠状动脉血流动力学的影响。
Aust N Z J Med. 1985 Dec;15(6):685-90.
7
Inhibition of leukotriene actions by the calcium channel blocker, nisoldipine.
Proc Soc Exp Biol Med. 1986 Jul;182(3):296-300. doi: 10.3181/00379727-182-42342.
8
Effect of calcium antagonist darodipine on the isolated human heart.钙拮抗剂达罗地平对离体人心脏的作用。
Eur J Pharmacol. 1986 Jun 17;125(2):287-91. doi: 10.1016/0014-2999(86)90039-7.
9
A model for the study of coronary spasm induced changes in cardiac metabolism.一种用于研究冠状动脉痉挛引起的心脏代谢变化的模型。
J Mol Cell Cardiol. 1985 Sep;17(9):917-30. doi: 10.1016/s0022-2828(85)80105-x.
10
Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.钙拮抗剂尼索地平与硝苯地平在血液灌注犬心脏中的心血管特性
Arzneimittelforschung. 1986 Jul;36(7):1054-9.